MSB 3.21% $1.13 mesoblast limited

MSB Trading 2021 - paradigm shift, page-140

  1. 2,273 Posts.
    lightbulb Created with Sketch. 374



    "Long Covid is relatively not common. It still requires treatment early and widely. No one knows who will get long Covid. Also, although distressing, most long Covid symptoms reduce over time."

    Now I can confidently say you have aboslutely no evidence of this as long term studies have not been completed. I think at this point we have limited data and idea what we are dealing with from a health perspective on long term function, quality of life and impact on vocational outcomes etc etc
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.